This inventor holds 1 USPTO granted patent. Top assignee: Virginia Commonwealth University. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Innovations in Cardiovascular Treatments by Earl F Ellis
Introduction
Earl F Ellis is a notable inventor based in Midlothian, VA (US). He has made significant contributions to the field of cardiovascular medicine through his innovative research and patenting efforts. His work focuses on the therapeutic applications of cannabinoid compounds in treating various cardiovascular conditions.
Latest Patents
Earl F Ellis holds a patent for "Cardiovascular uses of cannabinoid compounds." This patent addresses the treatment of hemorrhagic shock and other conditions associated with excessive vasoconstriction, such as hypertension, peripheral vascular disease, cirrhosis of the liver, and certain forms of angina pectoris. The patent highlights the use of agonists of CB1 receptors and other cannabinoid receptors as a potential treatment method. Furthermore, it suggests that in cases of septic shock and cirrhosis of the liver, where hypotension is caused by macrophage activation due to bacterial endotoxin, a drug that selectively blocks CB1 receptors may provide therapeutic benefits by preventing or reducing endotoxin-induced hypotension.
Career Highlights
Earl F Ellis is affiliated with Virginia Commonwealth University, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from severe cardiovascular conditions.
Collaborations
Earl F Ellis has collaborated with esteemed colleagues such as George Kunos and Karoly Varga. Their combined expertise has contributed to the advancement of research in cannabinoid applications in medicine.
Conclusion
Earl F Ellis's innovative work in the field of cardiovascular treatments showcases the potential of cannabinoid compounds in addressing critical health issues. His contributions through patenting and research continue to pave the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
